Amplicon details |
||
Amplicon: |
215 bp | |
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 151 aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc 201 gccaggctca aggcg |
||
| Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
|---|---|---|---|---|---|---|---|
| LY543960.1 | emblrelpat | KR 1020170133500-A/4: PRODUCTION OF... | 13524 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY543983.1 | emblrelpat | KR 1020170126032-A/53: Immuno-Based... | 7570 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY543984.1 | emblrelpat | KR 1020170126032-A/55: Immuno-Based... | 6259 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY566940.1 | emblrelpat | KR 1020180100028-A/1: Preparation P... | 6216 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY566941.1 | emblrelpat | KR 1020180100028-A/2: Preparation P... | 6219 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY566962.1 | emblrelpat | KR 1020180100802-A/4: Recombinant v... | 4911 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| MO547850.1 | emblrelpat | Sequence 7 from patent US 10487346. | 5049 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
| LY582037.1 | emblrelpat | KR 1020180091768-A/5: BIOACTIVE SUB... | 6330 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY582264.1 | emblrelpat | KR 1020180099537-A/2: PHARMACEUTICA... | 6216 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY582968.1 | emblrelpat | KR 1020180113183-A/19: NK cell acti... | 8748 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY583542.1 | emblrelpat | KR 1020180124777-A/73: MARKER COMPO... | 4620 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY590020.1 | emblrelpat | KR 1020180081811-A/9: METHOD FOR CO... | 14551 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY590021.1 | emblrelpat | KR 1020180081811-A/10: METHOD FOR C... | 14569 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY590198.1 | emblrelpat | KR 1020180084135-A/16: METHOD OF PR... | 4241 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY590200.1 | emblrelpat | KR 1020180084135-A/18: METHOD OF PR... | 2406 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY590202.1 | emblrelpat | KR 1020180084135-A/20: METHOD OF PR... | 5754 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY590203.1 | emblrelpat | KR 1020180084135-A/21: METHOD OF PR... | 5708 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY590205.1 | emblrelpat | KR 1020180084135-A/23: METHOD OF PR... | 5700 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY590206.1 | emblrelpat | KR 1020180084135-A/24: METHOD OF PR... | 7086 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
| LY590208.1 | emblrelpat | KR 1020180084135-A/26: METHOD OF PR... | 5152 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.